SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-025170
Filing Date
2017-04-04
Accepted
2017-04-04 17:37:58
Documents
1
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7392
  Complete submission text file 0001209191-17-025170.txt   8938
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences

Mailing Address
Business Address
GARRITY THOMAS J (Reporting) CIK: 0001275012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 17739884